Posted in | Lab Techniques | Biomarkers

Exploring disease biomarkers with LC-MS/MS omics for clinical research

Mass spectrometry combined with liquid chromatography (LC-MS/MS) is changing clinical research by facilitating the exact detection and measurement of disease-specific biomarkers. 

When combined with other omics procedures (metabolomics, lipidomics, and proteomics), this technology provides unparalleled sensitivity, specificity, and multiplexing capabilities. These benefits enable researchers to explore the biological basis of disease and personalize treatment regimens with more certainty.

Join top specialists in clinical metabolomics, Professor Martin Giera (Leiden University Medical Center) and Professor Antonin Lamazière (Sorbonne University and Saint Antoine's Hospital), as they discuss how LC-MS/MS-based omics technologies are improving disease mechanism profiling.

What will you learn?

  • Best practices for developing LC-MS/MS assays to accurately detect and quantify disease-related biomarkers in clinical samples
  • How to use LC-MS/MS to create innovative metabolomic and lipidomic procedures, revealing disease markers and deepening understanding
  • How recent advancements in LC-MS/MS technology and bioinformatics have improved sensitivity, throughput, and reliability for biomarker identification
  • Advanced MS techniques to track lipidomic and metabolomic alterations, providing insights into disease onset and development

Speakers

  • Martin Giera: Professor for Translational Metabolomics and Lipidomics, Leiden University Medical Center

  • Antonin Lamazière: Professor and Hospital Practitioner (Sorbonne University's Faculty of Medicine) and Department Head, Department of Clinical Metabolomics (Saint Antoine’s Hospital)

Other Webinars from SCIEX

Life Science Webinars by Subject Matter

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.